Literature DB >> 3040424

Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.

C D Gregory, C Kirchgens, C F Edwards, L S Young, M Rowe, A Forster, T H Rabbitts, A B Rickinson.   

Abstract

A series of lymphoblastoid cell lines (LCLs) have been established by in vitro infection of fetal bone marrow and fetal liver cells with Epstein-Barr virus (EBV). While most lines showed the usual mature B cell phenotype, a small proportion were cytoplasmic and surface immunoglobulin (Ig) heavy and light chain negative. Analysis of gene rearrangements indicated that the Ig- lines were either germ-line or nonproductively rearranged when probed for JH and were in germ-line configuration for C chi; no mu or chi mRNA could be detected in such cells. Precursor B cell lines were indistinguishable from their normal Ig+ counterparts in their expression of a wide variety of cell surface markers including "activation" antigens usually associated with the lymphoblastoid state; even the single LCL showing germ-line heavy and light chain genes expressed B lineage-specific cell surface antigens. However, the Ig- lines were distinct from their Ig+ counterparts in three important respects: (a) they grew much more slowly and achieved lower saturation densities, (b) they showed unusually high proportions (8-16%) of cells in EBV-productive cycle, and (c) they contained unusually high proportions (up to 40%) of cells expressing free joining (J) chain. These results suggest that precursor B cells differ in their response to the growth-transforming effects of EBV such that the virus-cell interaction in precursor B cell lines is inherently less stable than in conventional LCL. In particular there may be a greater movement of cells out of cycle and along the B cell maturation pathway. It is possible that such movement leads in individual cells either to virus replication or to a "sterile" plasmacytoid differentiation with J chain expression in the absence of Ig synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040424     DOI: 10.1002/eji.1830170818

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.

Authors:  R J Murray; L S Young; A Calender; C D Gregory; M Rowe; G M Lenoir; A B Rickinson
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.

Authors:  J B Mannick; J I Cohen; M Birkenbach; A Marchini; E Kieff
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

Authors:  S C Kenney; E Holley-Guthrie; E B Quinlivan; D Gutsch; Q Zhang; T Bender; J F Giot; A Sergeant
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the mu chain gene and other chromosomes.

Authors:  E Altiok; G Klein; L Zech; M Uno; B E Henriksson; S Battat; Y Ono; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Light-chain gene expression before heavy-chain gene rearrangement in pre-B cells transformed by Epstein-Barr virus.

Authors:  H Kubagawa; M D Cooper; A J Carroll; P D Burrows
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

Authors:  E B Quinlivan; E A Holley-Guthrie; M Norris; D Gutsch; S L Bachenheimer; S C Kenney
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

7.  Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.

Authors:  Christoph Mancao; Markus Altmann; Berit Jungnickel; Wolfgang Hammerschmidt
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

8.  Prognostic value of TROP2 in human nasopharyngeal carcinoma.

Authors:  Guo-Fang Guan; De-Jun Zhang; Lian-Ji Wen; Duo-Jiao Yu; Yan Zhao; Lin Zhu; Ying-Yuan Guo; Ying Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.

Authors:  C Schmid; L Pan; T Diss; P G Isaacson
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

10.  Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.

Authors:  Emily Heath; Noelia Begue-Pastor; Sridhar Chaganti; Debbie Croom-Carter; Claire Shannon-Lowe; Dieter Kube; Regina Feederle; Henri-Jacques Delecluse; Alan B Rickinson; Andrew I Bell
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.